What is LLY's current stock price?

As of now, LLY is trading at $1107.12, with a daily change of +10.33%.

What are the risks associated with LLY stock?

LLY has Low, risk level based on volatility, sector strength, volume, investor confidence and outlook.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

LLY Stock Analysis & IQ Rating | Eli Lilly and

LLY LLY Badge

Eli Lilly and

$1107.12

+$103.66 | +10.33%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$1133.95

MKT CAP

$1.05T

52W Low

$623.78

VOL

$7.09M

P/E Ratio

54.14

AVG VOL

$2.81M

RSI

59.86

TREND

Uptrend

LLY Stock IQ

Login to see Eli Lilly and (LLY) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

LLY Target Price

Login to display

Strengths

LLY Rewards

Earnings are forecast to grow

LLY Rewards

Upgraded on attractively valued

LLY Rewards

Trading below its fair value

LLY Rewards

Outperform the market

LLY Price Performance

$1041.51 (+6.30%)

$925.81 (+19.58%)

$750.61 (+47.50%)

$857.2 (+29.16%)

1year

6month

3month

1month

LLY Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

LLY Analysts Opinion

LLY Analysts opinion is positive and also has improved from the past 3 months

LLY Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

87%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

62%

86%

LLY Street Sentiment

LLY Street Sentiment is extremely bullish and have positive views on the near-term outlook

LLY Risk Level

LLY has Low risk level

Risks Indicators

Investors losing confidence

Low

LOW

HIGH

LLY Performance Sentiment

Sentiments overview associated with events and the stock performance

87%

12%

Positive

Negative

123 out of 141
events present

17 out of 141
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$1037.15

Resistance
Price

$1023.80

Current Price Range

$1109.94

Show methods +

Analyst Consensus

Recent Upgrades and Downgrades

100%

Buy

Hold

Sell

Consensus Rating

STRONG BUY

16

0

Date

Action

Rating

Firm

Jan 09, 2026

Initiate

Buy

UBS

Dec 22, 2025

Reiterate

Buy

BofA

Dec 18, 2025

Upgrade

Buy

Goldman Sachs

Dec 16, 2025

Reiterate

Buy

B of A Securities

Dec 08, 2025

Reiterate

Buy

Guggenheim

Linked to LLY

Close Price

Change

NVO

Novo Nordisk A/S

47.19

-6.18%

PFE

Pfizer

26.78

+3.92%

SNY

Sanofi

48.08

+1.24%

ABBV

AbbVie

217.11

-3.79%

NVS

Novartis AG

152.91

+2.04%

Recently Viewed

Close Price

Change

LLY

Eli Lilly and

1107.12

+10.33%

POST

Post Holdings

104.47

+1.93%

LYFT

Lyft

16.16

-3.58%

ORCL

Oracle

146.67

-5.17%

TRGP

Targa Resources

204.44

+0.39%

LLY Latest Analysis +

Eli Lilly Issues FY26 Guidance . (RTTNews) - Eli Lilly and Company (LLY) said for fiscal 2026 the company projects: earnings per share in a range of $33.50 to $35.00 and revenue of $80 to $83 billion. The company expects continued momentum from Mounjaro and Zepbound worldwide and growth from key products inc

Today

$1107.12 | +10.33%

Activity

Eli Lilly (LLY) Q4 Earnings and Revenues Beat Estimates. Lilly (LLY) delivered earnings and revenue surprises of 7.88% and 7.95% respectively for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Today

$1107.12 | +10.33%

Earnings

Eli Lilly Soared by 39% in 2025 but Heres Another Healthcare Stock to Buy in 2026. Key PointsEli Lilly has leading products in the GLP-1 space with plans to bring pill versions of its weight loss shots to market.

Today

$1107.12 | +10.33%

Potential

Eli Lilly: A Wonderful Company But A Stock Priced For Perfection.

Today

$1107.12 | +10.33%

Potential

Eli Lilly Non-GAAP EPS of $7.54 beats by $0.61 revenue of $19.29B beats by $1.35B.

Today

$1107.12 | +10.33%

Earnings

Earnings Snapshot: Eli Lilly tops FY guidance expectations on strong Mounjaro Zepbound sales.

Today

$1107.12 | +10.33%

Activity

Mounjaro Maker Eli Lilly Banks On Bigger 2026 Thanks To Weight Loss Drugs. ) stock is trading higher after the company released better-than-expected Q4 earnings and .Eli Lilly reported fourth-quarter adjusted earnings of $7.54 per share beating .The company'.s sales reached $19.3 billion beating the consensus of $17.96 billion.Sales jumped 43% year over year driven by a 46% increase in volume partially offset by a 5% decrease due to lower realized prices.Gross profit increased 43% to $15.9 b

Today

$1107.12 | +10.33%

Earnings

Momentum

Eli Lilly Surges 9% After Obliterating Forecasts As Mounjaro Zepbound Sales Double.

Today

$1107.12 | +10.33%

Momentum

Eli Lilly blows past quarterly estimates posts strong outlook as Zepbound and Mounjaro sales soar. Eli Lillys fourth-quarter earnings come as it tries to maintain its advantage over Novo Nordisk in the GLP-1 market.

Today

$1107.12 | +10.33%

Activity

Potential

Eli Lilly sees 2026 profit above estimates as demand for weight‑loss drugs soars.

Today

$1107.12 | +10.33%

Earnings

Momentum

FAQ About LLY Stock Insights

What is LLY current stock price?

What are LLY stock strengths?

What is LLY Risk Level?

What is LLY market cap and volume?

What is LLY current Stock IQ?

Should I buy LLY stock right now?

Is LLY a Strong Buy right now?

What does a 'Strong Buy' rating mean for LLY?

What does a 'Strong Sell' rating mean for LLY?

What factors influence LLY's Stock IQ?

Explore our LLY Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored LLY Stock Strategies
Effective Risk Management

FIND US ON

Receive our LLY Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

LLY LLY Badge

Eli Lilly and

Set Alerts

Current Price

$1107.12

+$103.66 | +10.33%

52W High

$1133.95

MKT CAP

$1.05T

52W Low

$623.78

VOL

$7.09M

P/E Ratio

54.14

AVG VOL

$2.81M

RSI

59.86

TREND

Uptrend

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Linked to LLY

Symbol

Close

Change

NVO

Novo Nordisk A/S

47.19

-6.18%

PFE

Pfizer

26.78

+3.92%

SNY

Sanofi

48.08

+1.24%

ABBV

AbbVie

217.11

-3.79%

NVS

Novartis AG

152.91

+2.04%

LLY Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

87%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

62%

86%

LLY Street Sentiment

LLY Street Sentiment is extremely bullish and have positive views on the near-term outlook

LLY Risk Level

LLY has Low risk level

Risks Indicators

Investors losing confidence

Low

LOW

HIGH

LLY Performance Sentiment

Sentiments overview associated with events and the stock performance.

87%

12%

Positive

Negative

123 out of 141
events present

17 out of 141
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$1037.15

Resistance
Price

$1023.80

Current Price Range

$1109.94

Show methods +

Latest Analyst Actions

Overall Wall Street Rating

100%

Buy

Hold

Sell

Consensus Rating

STRONG BUY

16

0

Date

Action

Rating

Firm

Jan 09, 2026

Initiate

Buy

UBS

Dec 22, 2025

Reiterate

Buy

BofA

Dec 18, 2025

Upgrade

Buy

Goldman Sachs

Dec 16, 2025

Reiterate

Buy

B of A Securities

Dec 08, 2025

Reiterate

Buy

Guggenheim

LLY Stock IQ

Login to unlock Eli Lilly and (LLY) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

LLY Rewards

Earnings are forecast to grow

LLY Rewards

Upgraded on attractively valued

LLY Rewards

Trading below its fair value

LLY Rewards

Outperform the market

LLY Latest Analysis

Eli Lilly Issues FY26 Guidance . (RTTNews) - Eli Lilly and Company (LLY) said for fiscal 2026 the company projects: earnings per share in a range of $33.50 to $35.00 and revenue of $80 to $83 billion. The company expects continued momentum from Mounjaro and Zepbound worldwide and growth from key products inc

Today

$1107.12 | +10.33%

Activity

Eli Lilly (LLY) Q4 Earnings and Revenues Beat Estimates. Lilly (LLY) delivered earnings and revenue surprises of 7.88% and 7.95% respectively for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Today

$1107.12 | +10.33%

Earnings

Eli Lilly Soared by 39% in 2025 but Heres Another Healthcare Stock to Buy in 2026. Key PointsEli Lilly has leading products in the GLP-1 space with plans to bring pill versions of its weight loss shots to market.

Today

$1107.12 | +10.33%

Potential

Eli Lilly: A Wonderful Company But A Stock Priced For Perfection.

Today

$1107.12 | +10.33%

Potential

Eli Lilly Non-GAAP EPS of $7.54 beats by $0.61 revenue of $19.29B beats by $1.35B.

Today

$1107.12 | +10.33%

Earnings

Earnings Snapshot: Eli Lilly tops FY guidance expectations on strong Mounjaro Zepbound sales.

Today

$1107.12 | +10.33%

Activity

Mounjaro Maker Eli Lilly Banks On Bigger 2026 Thanks To Weight Loss Drugs. ) stock is trading higher after the company released better-than-expected Q4 earnings and .Eli Lilly reported fourth-quarter adjusted earnings of $7.54 per share beating .The company'.s sales reached $19.3 billion beating the consensus of $17.96 billion.Sales jumped 43% year over year driven by a 46% increase in volume partially offset by a 5% decrease due to lower realized prices.Gross profit increased 43% to $15.9 b

Today

$1107.12 | +10.33%

Earnings

Momentum

Eli Lilly Surges 9% After Obliterating Forecasts As Mounjaro Zepbound Sales Double.

Today

$1107.12 | +10.33%

Momentum

Eli Lilly blows past quarterly estimates posts strong outlook as Zepbound and Mounjaro sales soar. Eli Lillys fourth-quarter earnings come as it tries to maintain its advantage over Novo Nordisk in the GLP-1 market.

Today

$1107.12 | +10.33%

Activity

Potential

Eli Lilly sees 2026 profit above estimates as demand for weight‑loss drugs soars.

Today

$1107.12 | +10.33%

Earnings

Momentum

Discover LLY Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of LLY. We're here to help you make informed investment decisions today.

FIND US ON

Receive our LLY Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

LLY Stock trends

LLY Stock performance

LLY Stock analysis

LLY investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing LLY

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing LLY

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

LLY Stock Analysis & IQ Rating | Eli Lilly and

LLY Stock IQ

LLY Target Price

LLY Analysts Opinion

LLY Street Sentiment

LLY Risk Level

LLY Performance Sentiment

Key Price Levels

Analyst Consensus

Explore our LLY Stock insights

Receive our LLY Daily Alerts

LLY Street Sentiment

LLY Risk Level

Key Price Levels

Latest Analyst Actions

Discover LLY Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of LLY. We're here to help you make informed investment decisions today.

Receive our LLY Daily Alerts

LLY Alerts